eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2021
vol. 59
 
Share:
Share:
abstract:
Case report

Clinicopathological characteristics of multiple intracranial Rosai-Dorfman disease with increased IgG4-positive plasma cells: a report of two cases

Chunhui Zhou
1
,
Hongxiang Ren
2
,
Liu Hong
3
,
Jianning Zhang
1
,
Hongxiang Wang
4

1.
Department of Neurosurgery, The Sixth Medical Center of PLA General Hospital, Beijing, China
2.
Department of Neurosurgery, China-Japan Friendship Hospital, Capital University of Medical, Beijing, China
3.
Department of Pathology, The Sixth Medical Center of PLA General Hospital, Beijing, China
4.
Department of Neurosurgery, Changhai Hospital, Naval Military Medical University, Shanghai, China
Folia Neuropathol 2021; 59 (4): 409-418
Online publish date: 2021/12/30
View full text Get citation
 
PlumX metrics:
Rosai-Dorfman disease (RDD) is an uncommon condition characterized by the proliferation of histiocytes and multiple intracranial involvements and it is extremely rare. Here, we present two cases of multiple intracranial RDD mimicking meningioma. These patients underwent surgery for tumour resection and pathological findings revealed an increased number of IgG4-positive plasma cells in RDD. The radiographic appearance and histology may contribute to a diagnostic dilemma, and immunohistochemical and serological examinations are a necessary complement for definitive diagnosis. Treatment protocols pertaining to such types of RDD cases are reviewed. Currently, surgical resection is the most effective therapy, and steroid therapy, radiotherapy, or chemotherapy may be provided as adjuvant treatments in some selected patients.
keywords:

Rosai-Dorfman disease, multiple intracranial lesions, IgG4, diagnosis, treatment

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.